Direct control of mitochondrial function by mTOR
Arvind Ramanathan
Stuart L. Schreiber1
Chemical Biology Program, Broad Institute of Harvard and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, MA 02142

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.. Effect of rapamycin on mitochondria and glycolysis. (A) Jurkat cells were treated with 100 nM rapamycin in the presence or absence of the transcription inhibitor actinomycin D for 45 min. (B) Levels of maximally uncoupled respiration were measured after treatment with rapamycin or vehicle for 30 min, followed by treatment with 1 µm FCCP for 15 min. (C) Levels of lactic acid in the extracellular medium were measured after cells were treated with rapamycin for 45 min. *, P < .05. All experiments were performed in biological triplicate.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.. mTOR affects mitochondrial metabolism via a complex with Bcl-xl. (A) Bcl-xl interacts with mTOR and VDAC1. Interaction of Bcl-xl with mTOR was decreased by treatment with rapamycin. (B) An in vitro kinase assay was performed using recombinant purified mTOR and Bcl-xl proteins and P32-labeled ATP. Bcl-xl was detected using a Ponceau stain, and the phosphorylated serine 62 on Bcl-xl was detected using an antibody. (C) mTOR-mediated phosphorylation of Bcl-xl was monitored using recombinant, purified Bcl-xl protein at indicated concentrations, using an ATP-coupled luminescence assay, with 100 ng of mTOR protein used per reaction. (D) Jurkat cells were treated with rapamycin and ABT-263 at indicated concentrations, and oxygen consumption was measured. (E) Jurkat cells overexpressing either GFP or Bcl-xl were treated with DMSO vehicle or rapamycin, and oxygen consumption was measured. *, P < .05. All experiments were preformed in biological triplicate.
|
|